- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic High Grade Fallopian Tube Serous Adenocarcinoma, +27 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
Clinical trial condition
Recurrent High Grade Fallopian Tube Serous Adenocarcinoma
Explore clinical trials studying Recurrent High Grade Fallopian Tube Serous Adenocarcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Recurrent High Grade Fallopian Tube Serous Adenocarcinoma trial results
Active, Not Recruiting
Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients
NCT05114421
- Conditions
- High Grade Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Peritoneal High Grade Serous Adenocarcinoma, +3 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Related conditions
- Recurrent High Grade Ovarian Serous Adenocarcinoma (2)
- Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma (2)
- Breast Diseases (1)
- Breast Neoplasms (1)
- High Grade Fallopian Tube Serous Adenocarcinoma (1)
- High Grade Ovarian Serous Adenocarcinoma (1)
- Metastatic High Grade Fallopian Tube Serous Adenocarcinoma (1)
- Metastatic Malignant Solid Neoplasm (1)